VEGF-D Antibodies

Santa Cruz Biotechnology delivers a wide array of VEGF-D monoclonal antibodies for research in vascular biology and related fields. VEGF-D Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Vascular Endothelial Growth Factor D (VEGF-D) plays a crucial role in lymphangiogenesis and angiogenesis, influencing the formation of new blood vessels and lymphatic vessels. VEGF-D is involved in various physiological and pathological processes, including cancer progression and inflammatory responses, highlighting its importance in biomedical research. Understanding VEGF-D function can provide insights into therapeutic targets for diseases characterized by abnormal vascular growth. Researchers can explore molecular mechanisms underlying vascular development using specific detection methods. Advanced visualization techniques enable detailed examination of VEGF-D expression patterns in different tissue types. Precise monitoring of VEGF-D activity helps reveal its role in disease progression. Santa Cruz Biotechnology monoclonal antibodies support the scientific community by enabling detailed investigation of VEGF-D's role in vascular biology and disease mechanisms.